HBM4EU project deliverables
The page lists 77 deliverables related to the research project "HBM4EU".
List of Deliverables
| title and desprition | type | last update |
|---|---|---|
Report on approaches to identify mixture health effects (UBRUN)This report provides a description of viable approaches to describe and assess mixture health effects for relevant mixtures identified under tasks 15.1 and 15.2 and proposes topical cases studies as proof of concept. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2020 Programme of training activities, materials and capacity building mechanisms (RUMC)The 2020 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2020. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2nd review of training methods (RUMC)A second review of the training materials that have been produced and used under the HBM4EU training programme. This may include both materials developed by the HBM4EU teams, as well as materials developed under other relevant initiatives. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report information needs from policy makers translated in terms of functionality of HBM mixture informationThis report describes the results of the consultation of information needs policymakers and stakeholders with respect to mixtures and gap analysis. The report will further outline the challenges and direction of research activities in Task 15.1, 15.2 and 15.3 to serve the information needs. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Second report on biobank activities (KI)Report on progress with Biobanks – the establishment of permanent networks and links with HBM4EU. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Second report on targeted new fieldwork and resultsReport on the first fieldwork results and the proposal and progress with the second field work following the second prioritisation round. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2020 Strategy for the communication and dissemination of HBM4EU resultsAn update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2020 AWP. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Scoping documents for 2020The scoping document will outline targeted research activities proposed for 2020 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2019 Programme of training activities, materials and capacity building mechanisms (RUMC)The 2019 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2019. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st Report on analytical results and new methods development (IPA)Results obtained by the qualified laboratories and the achievements and problems encountered during the development of new methods. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on estimation of relevant tissue and biological fluid doses of 1st set of priority compounds in the EU population using refined PBTK modelingThis report will provide estimates of the risk characterization ratios for the 1st set of priority substances based on the results of the quantitative estimates of exposure derived in task 12.2.a. In this context, any new regulatory thresholds discussed at the policy level for the 1st set of priority substances will be evaluated vis-Ã -vis the exposure estimates generated using the exposure reconstruction algorithms developed in HBM4EU. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Sustainability of HBM4EU in the future and related operational architecture concept: first reportThis initial report will provide specific proposals for the future of the initiative based on our initial interactions with a large number of bodies. It will include the mechanisms of cooperation with DG RTD, the financial plans for 2021-2030, a governance structure and an institutional anchor at EU level. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Revised set of key indicators (DOMG)We will revise the set of indicators following the first 2.5 years of the initiative and add, delete or modify the previous indicators taking into account societal, scientific, policy and stakeholder perspectives. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Identified gaps for the establishment of AOPs and required studiesThis deliverable will report on the knowledge gaps identified in order to complete the establishment of AOPs for the 1st and 2nd list of priority substances in HBM4EU. It will also include a description of the studies (-omics, functional assays, etc.) necessary to complete the identified AOP knowledge gaps. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2nd substance-group specific risk assessment2nd substance-group specific risk assessment based on HBM data of first round priority substances collected in HBM4EU. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st update on the report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelinesUpdate of the report under D11.1 adding new information about on-going/planned studies and updates to the SOPs based on the 2nd prioritization round. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2nd-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and samplingDetailed working documents are provided for recruitment and sampling for the study conduct for the second prioritized substances to close identified data gaps. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report Outline and workplan for the joint survey on HBM mixtures (IRAS)This report describes the gaps in existing data as identified under 15.1, the outcome of the CGL and MS and EC institutions’ consultation, and outlines the workplan for a joint HBM survey on mixtures in 3-5 MS. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Databases of candidate laboratories for the 2nd prioritization round of substances (ULPGC)Database of the laboratories considered as candidate to perform the analysis of samples, to develop new methods and to support the QA/QC Program considering the substances included in the first round of prioritization. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2nd material for communication to participants, including informed consentNecessary material to communicate with the participants are compiled and examples for the second prioritised substances provided. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st Phased Action Plan for translation of HBM results into policy advise, measures and suggestions for further research at general level (UAntwerpen)A generic canvas for policy interpretation of the HBM findings based on the input from EU policy board members; policy makers and stakeholders. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Initial report on occupational studiesInitial proposals and research plan for targeted occupational studies with EU added value on priority substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Statistical Analysis Plan for each substance group for 1st set of substances (ISGlobal)The statistical analysis plan describes the statistical analyses that will be performed to test the hypotheses that are formulated as part of the study protocol for each of prioritized substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st Report on stakeholder consultation and mapping of needsThe report will summarise the outcomes of the 2017-2018 consultation on the prioritisation process, and will include a list of users of HBM4EU outputs and an inventory of gaps and needs, as well as the list of key terms and definitions. The report will be presented to the Governing Board and the Stakeholder Forum in support of the proposed list of priority substances and proposed CGLs. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
HBM4EU websiteThe HBM4EU website will promote the project and serve as an access point for results, including a link to IPCheM, as well as linking with other relevant projects. It will features an online library including technical materials on protocols and analytical methods, as well as training materials and guidance. It will also serve as an internal communication tool, featuring web pages for internal information sharing accessible via password. Continuous updates will ensure that the website is dynamic and effective as an information hub for the initiative. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Websites, patent fillings, videos etc. | 2020-03-25 |
Scoping paper on the development of an indicator on chemical exposure in the European populationThe indicator will use HBM data for follow up of chemical exposure of the EU population. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Review paper on PBTK/D models for the 1st set of priority compoundsThis is a review paper (to be published in the peer-reviewed literature) on current state of the art in PBTK/D modeling regarding the 1st set of priority compounds – analysis of capabilities and limitations and need for further refinement. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2019 Strategy for the communication and dissemination of HBM4EU resultsAn update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2019 AWP. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on ongoing activities and existing data and data gaps for the 2nd prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL)The existing information about the substances prioritised in the second prioritisation round (M18) on ongoing or within the next five years initiated or planned studies in the field of HBM (general population and occupational exposure) and health will be reported and data gaps identified. Metadata that can be uploaded in IPCheM will be compiled. FMUL is an LTP to FCT and is responsible for this deliverable. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Inventory of available samples and data collected from existing cohorts and preliminary results on exposure-response associations for 1st list of priority substancesThis deliverable will provide a comprehensive inventory of all previously collected samples and data (including the inventory prepared in WP7 and WP8) that will be available and useful for the derivation of robust exposure-response relationships for the 1st list of priority substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Statistical Analysis Plan for each substance group for 2nd set of substances (ISGlobal)The statistical analysis plan describes the statistical analyses that will be performed to test the hypotheses that are formulated as part of the study protocol for each of prioritized substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
The Quality Assurance/Quality Control Scheme in HBM4EU project (IPASUM)Overview of the different approaches to be implemented in the HBM4EU project to cover the necessities in the different prioritization rounds. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
List of biomarkers for the 1st set of prioritized substances (UGR)Report of selected effect biomarkers selected for the 1st set of prioritised substances, including those that can provide integrated information on delineating the mode(s) of action (MOA) of the adverse response or toxicity. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report real-life exposure profiles from re-analysis of existing HBM mixture dataThe report describes available HBM mixture data and presents and discusses the results from the re-analysis of compiled database of existing HBM mixture data. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on biological half-lives of 1st set of priority compoundsThis report will provide the values of the biological half-lives of the 1st set of priority compounds targeted in HBM4EU on the basis of the PBTK modeling results. The PBTK models will have been parameterized and upgraded based on the experimental data obtained in task 12.3.b. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on the optimal methodology for exposure reconstruction from HBM dataThis report will lay out the tiered methodology for exposure reconstruction from HBM data – the methodology will be structured in tiers on the basis of data availability and model estimation capacity for the compounds targeted in HBM4EU. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2017 Strategy for the communication and dissemination of HBM4EU resultsThe Strategy for the communication and dissemination of HBM4EU results will frame our key messages and identifying target audiences and relevant communication tools. The Strategy will include a publication plan, establishing a policy for the publication of articles in scientific journals, including such issues as authorship, as well as proposing processes to ensure that policy makers have access to results without undue delays caused by journal publication timeframes. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on ongoing activities and existing data and data gaps for the 1st prioritised substances including a list of metadata that can be uploaded in IPCheM (FMUL)The existing information about the substances prioritised in the period of proposal preparation on ongoing or within the next five years initiated or planned studies in the field of HBM (general population and occupational exposure) and health will be reported and data gaps identified. Metadata that can be uploaded in IPCheM will be compiled. FMUL is an LTP to FCT and is responsible for this deliverable. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Prioritised list of biomarkers, matrices and analytical methods for the 1st prioritization round of substancesA list with the selected biomarkers, matrices and analytical methods selected according to the criteria defined in task 9.1 and considering the substances included in the first round of prioritization. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on available biomarkers of effect of proven utility in human epidemiological studies for the 1st set of prioritised substances (UGR)A list of biomarkers based on the human health effects, the quality of the assay and its usefulness for large population studies, which provide the most significant added value to HBM4EU by linking exposure data to measures of biological effects. This deliverable will also report on the outcome of the workshop organised in M18, as well as, the meta-analysis on existing data, if appropriate. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Legal and Ethics Policy document (UCPH)A legal, ethics, and intellectual property rights framework in parallel and in coordination with the Data Management Plan under task 10.1 to ensure that procedures for the collection, collation, transfer and use of HBM data fully respect data management and privacy legislation both at EU and at national level. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Templates for the submission of urgent requests for new information, one for EU policy makers and one for national policy makers (ANSES)The templates will provide a consistent approach to the submission of requests for action by HBM4EU under the rapid response mechanism. Templates will be produced for two communities, the EU policy community and the national policy makers. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Prioritisation strategy and criteria (ANSES)The prioritisation strategy will be transparent, credible and accountable and will set out the procedures by which substances will be prioritised for inclusion in HBM surveys, analysis and/or research under HBM4EU. Decisions regarding which substances to work on will be based on a set of criteria that capture both scientific evidence aspects, regulatory demands, societal concerns and take into account financial and technical feasibility. With regards to human exposure, the criteria will take into account environmental, consumer and occupational exposure pathways. ANSES is LTP to INSERM and is responsible for this deliverable. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on results of the selected biomarker of effect (UGR)Experimental work: Report on results of the validation of specific biomarker of effect (i.e., ex vivo cell-based functional assays) in a set of available collected human samples from ongoing/current studies. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
List of criteria for selecting cohort studiesThis deliverable will report on the criteria that will have be used to select data and samples needed for determining exposure-response associations for all priority substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Strategy and SOPs for human sample exchange, including ethical demands (IBMT)A strategy for the pan-European exchange of biobanked human samples is developed and laid down and SOPs including technical, legal and ethical requirements for the safe and standardized exchange elaborated. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Second list of prioritised substances and proposed CGLs for 2019-2021 (ANSES)The second list of prioritised substances will results from the prioritisation round from 2017 to 2018. It will identify substances that have been prioritised for inclusion in HBM surveys, analysis and/or research under HBM4EU in the three year period from 2019 to 2021. ANSES is LTP to INSERM and is responsible for this deliverable. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
First report on targeted new fieldwork study resultsReport on the new planned studies, the countries who will be involved and the material that has been prepared for these studies. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Description of national programmesDescription of national HBM programmes, which may align, to form a network for HBM4EU EJP. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on opportunities and obstacles of combining HBM and health studies, availability of health studies and administrative registers and guidelinesReport about what type of opportunities and obstacles were observed mainly in Germany, France and Israel when combining HBM and health studies, summary of the results to the questionnaires about on-going/planned health studies and administrative registers. SOPs for criteria for the use of existing biobanked samples for HBM analysis and guidelines for linking HBM and health studies Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Databases of candidate laboratories for the 1st prioritization round of substances (ULPGC)Database of the laboratories considered as candidate to perform the analysis of samples, to develop new methods and to support the QA/QC Program considering the substances included in the first round of prioritization. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st review of training methods (RUMC)A first review of the training materials that have been produced and used under the HBM4EU training programme. This may include both materials developed by the HBM4EU teams, as well as materials developed under other relevant initiatives. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Criteria for prioritisation of biomarkers of effect (UGR)List of criteria to select biomarkers of effect according to the type of study, the biological matrices where they have been developed, and to the analytical methods used in coordination to task 9.1. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Initial report on strategies adopted to align studies across Europe and preliminary resultsReport on the national studies which will align, the processes to integrate the requiremns from HBM4EU to these national structures and any obstacles. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2018 Strategy for the communication and dissemination of HBM4EU resultsAn update of the Strategy for the communication and dissemination of HBM4EU results to reflect the activities and outputs foreseen in the 2018 AWP. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Establishment of Stakeholder Forum and Advisory BoardSelection criteria and members of Stakeholder Forum (SF) and Advisory Board (AB). Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st substance-group specific derivation of EU-wide health based guidance valuesDerivation of health based guidance value for first round priority substances based on existing data. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
First set of key indicators (LNE Department)We will develop a first set of indicators capturing societal, scientific, policy and stakeholder perspectives, to measure the performance and impacts of the HBM4EU. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Workflows for screening emerging chemicals (INRA)Standardised workflows for broad “suspect chemical screening†of known emerging chemicals and for screening unknown emerging chemicals. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st annual list of exposure distributions and/or EU-wide reference valuesList of European reference values derived by analysis of consolidated data in IPCheM. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Report on workshop about opportunities and obstracles for linking HBM and health studiesReport about feasibility workshop with agenda, list of participants, presenations of the workshop and summary of the outcome. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
2018 Programme of training activities, materials and capacity building mechanisms (RUMC)The 2018 programme of training activities, materials and capacity building mechanisms will provide a time schedule for the activities planned for 2018. For each activity it will identify objectives linked to the AWP, partner/s responsible for delivering training, available training materials and the likely location of training (expect for online training). Links to any existing training activities at international level will also be identified, together with contact names. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st Report on the content and use of the online libraryThe report will detail the structure, functionalities and content of the online library. It will also report on usage over the first 21 project months, based on the number of online users and downloads from the library. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st substance-group specific risk assessmentThe first risk assessment will make use of already existing HBM data and will develop draft protocols for use in specific policy domains eg. food safety, chemical safety, occupational safety. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Scoping documents for 2019The scoping document will outline targeted research activities proposed for 2019 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Prioritized list of known emerging chemicals (IRAS)List of known chemicals (parent compounds or metabolites) to be considered as exposure markers of emerging concern. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Establishment of Governing BoardGoverning Board (GB) members and terms of reference for its meetings. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Criteria for prioritisation of biomarkers, matrices and analytical methods (ANSP)A list of the criteria that will be applied in the prioritization process of the biomarkers and matrices for the target substances. They will be general criteria and therefore common for the all prioritization rounds. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
First report on biobank activities (KI)Report on progress made to access biobanked samples from across Europe and how these samples will be used to address data gaps. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Prioritised list of biomarkers, matrices and analytical methods for the 2nd prioritization round of substancesA list with the selected biomarkers, matrices and analytical methods selected according to the criteria defined in task 9.1 and considering the substances included in the second round of prioritization. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st-priorisation-Report on survey design: Study protocols, SOPs and Guidelines, tailored and transferred questionnaires for recruitment and samplingDetailed working documents are provided for recruitment and sampling for the study conduct for the first prioritised substances to close identified data gaps. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
1st material for communication to participants, including informed consentNecessary material to communicate with the participants are compiled and examples for the first prioritised substances provided. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Data management planThe data management plan describes how existing and newly generated data are processed, managed, and quality controlled at the national level, harmonized, transferred and analysed at the European level and made available for different user communities. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Template for AOP update report for selected priority substancesThis deliverable will provide the comprehensive template that will have to be used to collect data on AOPs for the priority substances dealt with in HBM4EU. This will be fully compatible with the AOP KB of the OECD in order to ensure high level of coordination of the work done in WP13 with major international efforts in this domain. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Scoping documents for 2018The scoping document will outline targeted research activities proposed for 2018 and designed to address policy questions regarding a specific substance or group of substances. The descriptions will include goals, activities to be undertaken, methods, expected output and results, assumptions, constraints and budget estimates, as well as addressing ethical issues for each of the prioritized substances. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
First Report on national needs, objectives of a long-term HBM4EU, inventory of funding mechanisms and recommendations for a sustainable HBM initiative in Europe and its organisationThe report will be a comprehensive assessment of the long term needs and possible funding mechanisms. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-25 |
Selection criteria and inventory of effect biomarkers for the 2nd set of substances (UGR)Classification of the biomarkers of effect into 3 categories. Programme: H2020-EU.3.1.2. - Topic(s): SC1-PM-05-2016 |
Documents, reports | 2020-03-13 |